Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance

Paul A Bottomley, C. J. Hardy

Research output: Contribution to journalArticle

Abstract

This accurate, reliable, and fast method of assaying absolute concentrations of phosphate metabolites noninvasively in living tissue, including that of humans, combines 31P nuclear magnetic resonance (NMR) spectroscopy and 1H NMR imaging. The images are used to measure the areas of metabolite-bearing tissue in selected sections through the subject, and 31P spectra are acquired from the same section, together with a concentration reference located on the periphery. Metabolite concentrations are calculated from the ratios of areas and integrated signal intensities. Apparatus and protocol are designed to eliminate corrections due to magnetic field nonuniformities and NMR relaxation times. Mean (and SD) concentrations of adenosine triphosphate (ATP), phosphocreatine, and inorganic phosphate (P(i)) measured in the brains of 15 normal adult human volunteers with a 1.5-T NMR system were 3.03 (0.49), 5.18 (0.89), and 1.5 (0.7) mmol per liter of wet tissue, respectively. Acquisition times of only a few minutes should facilitate metabolic studies of patients with disorders in limbs and brain, particularly those affecting entire organs.

Original languageEnglish (US)
Pages (from-to)392-395
Number of pages4
JournalClinical Chemistry
Volume35
Issue number3
StatePublished - 1989
Externally publishedYes

Fingerprint

Metabolites
Assays
Magnetic Resonance Spectroscopy
Phosphates
Nuclear magnetic resonance
Tissue
Brain
Bearings (structural)
Phosphocreatine
Relaxation time
Nuclear magnetic resonance spectroscopy
Magnetic Fields
Adenosine Triphosphate
Magnetic fields
Imaging techniques
Volunteers
Extremities
Magnetic Resonance Imaging

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance. / Bottomley, Paul A; Hardy, C. J.

In: Clinical Chemistry, Vol. 35, No. 3, 1989, p. 392-395.

Research output: Contribution to journalArticle

@article{5035c9d45afa430f9bf120472e66c3a1,
title = "Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance",
abstract = "This accurate, reliable, and fast method of assaying absolute concentrations of phosphate metabolites noninvasively in living tissue, including that of humans, combines 31P nuclear magnetic resonance (NMR) spectroscopy and 1H NMR imaging. The images are used to measure the areas of metabolite-bearing tissue in selected sections through the subject, and 31P spectra are acquired from the same section, together with a concentration reference located on the periphery. Metabolite concentrations are calculated from the ratios of areas and integrated signal intensities. Apparatus and protocol are designed to eliminate corrections due to magnetic field nonuniformities and NMR relaxation times. Mean (and SD) concentrations of adenosine triphosphate (ATP), phosphocreatine, and inorganic phosphate (P(i)) measured in the brains of 15 normal adult human volunteers with a 1.5-T NMR system were 3.03 (0.49), 5.18 (0.89), and 1.5 (0.7) mmol per liter of wet tissue, respectively. Acquisition times of only a few minutes should facilitate metabolic studies of patients with disorders in limbs and brain, particularly those affecting entire organs.",
author = "Bottomley, {Paul A} and Hardy, {C. J.}",
year = "1989",
language = "English (US)",
volume = "35",
pages = "392--395",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "3",

}

TY - JOUR

T1 - Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance

AU - Bottomley, Paul A

AU - Hardy, C. J.

PY - 1989

Y1 - 1989

N2 - This accurate, reliable, and fast method of assaying absolute concentrations of phosphate metabolites noninvasively in living tissue, including that of humans, combines 31P nuclear magnetic resonance (NMR) spectroscopy and 1H NMR imaging. The images are used to measure the areas of metabolite-bearing tissue in selected sections through the subject, and 31P spectra are acquired from the same section, together with a concentration reference located on the periphery. Metabolite concentrations are calculated from the ratios of areas and integrated signal intensities. Apparatus and protocol are designed to eliminate corrections due to magnetic field nonuniformities and NMR relaxation times. Mean (and SD) concentrations of adenosine triphosphate (ATP), phosphocreatine, and inorganic phosphate (P(i)) measured in the brains of 15 normal adult human volunteers with a 1.5-T NMR system were 3.03 (0.49), 5.18 (0.89), and 1.5 (0.7) mmol per liter of wet tissue, respectively. Acquisition times of only a few minutes should facilitate metabolic studies of patients with disorders in limbs and brain, particularly those affecting entire organs.

AB - This accurate, reliable, and fast method of assaying absolute concentrations of phosphate metabolites noninvasively in living tissue, including that of humans, combines 31P nuclear magnetic resonance (NMR) spectroscopy and 1H NMR imaging. The images are used to measure the areas of metabolite-bearing tissue in selected sections through the subject, and 31P spectra are acquired from the same section, together with a concentration reference located on the periphery. Metabolite concentrations are calculated from the ratios of areas and integrated signal intensities. Apparatus and protocol are designed to eliminate corrections due to magnetic field nonuniformities and NMR relaxation times. Mean (and SD) concentrations of adenosine triphosphate (ATP), phosphocreatine, and inorganic phosphate (P(i)) measured in the brains of 15 normal adult human volunteers with a 1.5-T NMR system were 3.03 (0.49), 5.18 (0.89), and 1.5 (0.7) mmol per liter of wet tissue, respectively. Acquisition times of only a few minutes should facilitate metabolic studies of patients with disorders in limbs and brain, particularly those affecting entire organs.

UR - http://www.scopus.com/inward/record.url?scp=0024516364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024516364&partnerID=8YFLogxK

M3 - Article

C2 - 2920404

AN - SCOPUS:0024516364

VL - 35

SP - 392

EP - 395

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 3

ER -